Finlands Akademi
Finansieringsbeslut
 
Namn Skottman, Heli
Organisation TAY
Projektets titel Route map towards innovative cell replacement therapy for age-related macular degeneration
Beslutnr 304909
Beslutsdatum 30.09.2016
Finansieringsperiod 01.10.2016 - 30.09.2018
Finansiering 300 000
WebFOCUS Report
Beskrivning av projektet
The number of patients with blinding age related macular degradation (AMD) will double in the coming decades and there is no curative therapies available for the vast majority of patients with dry AMD. In this project, our aim has been to establish a proof-of-concept for the stem cell based treatment modality and boost the knowledge transfer towards regulatory approvals and human trials. During the project, we have gained significant new knowledge on the properties and function of the stem cell derived retinal pigment epithelial cells, improved their production methods and conducted cell transplantation studies with international collaborators. Simultaneously we are exploring possibilities and funding scheme to start clinical trials in Europe.